Cantor Fitzgerald Increases Tenet Healthcare (NYSE:THC) Price Target to $177.00

Tenet Healthcare (NYSE:THCGet Free Report) had its target price increased by stock analysts at Cantor Fitzgerald from $168.00 to $177.00 in a research note issued on Wednesday, Benzinga reports. The brokerage currently has an “overweight” rating on the stock. Cantor Fitzgerald’s price objective suggests a potential upside of 14.15% from the company’s previous close.

THC has been the subject of a number of other research reports. Citigroup increased their target price on shares of Tenet Healthcare from $139.00 to $171.00 and gave the stock a “buy” rating in a research report on Thursday, July 25th. The Goldman Sachs Group lifted their price objective on shares of Tenet Healthcare from $156.00 to $173.00 and gave the company a “buy” rating in a research note on Tuesday, July 30th. Truist Financial restated a “buy” rating and set a $190.00 target price (up previously from $180.00) on shares of Tenet Healthcare in a research report on Wednesday. KeyCorp initiated coverage on Tenet Healthcare in a research note on Friday, October 11th. They set an “overweight” rating and a $200.00 price objective on the stock. Finally, Raymond James raised their target price on Tenet Healthcare from $130.00 to $175.00 and gave the stock a “strong-buy” rating in a research note on Thursday, July 25th. One research analyst has rated the stock with a hold rating, fourteen have given a buy rating and four have given a strong buy rating to the company. According to data from MarketBeat.com, Tenet Healthcare has a consensus rating of “Buy” and an average price target of $163.65.

Read Our Latest Report on THC

Tenet Healthcare Stock Down 1.9 %

Tenet Healthcare stock opened at $155.06 on Wednesday. The company has a quick ratio of 1.38, a current ratio of 1.45 and a debt-to-equity ratio of 2.53. The company has a market capitalization of $14.86 billion, a P/E ratio of 5.69, a P/E/G ratio of 0.71 and a beta of 2.14. The firm has a 50 day moving average price of $159.55 and a 200-day moving average price of $141.69. Tenet Healthcare has a twelve month low of $51.04 and a twelve month high of $171.20.

Tenet Healthcare (NYSE:THCGet Free Report) last released its earnings results on Tuesday, October 29th. The company reported $2.93 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $2.33 by $0.60. The business had revenue of $5.12 billion during the quarter, compared to the consensus estimate of $5.05 billion. Tenet Healthcare had a return on equity of 24.66% and a net margin of 13.17%. The business’s revenue for the quarter was up 1.1% on a year-over-year basis. During the same period last year, the business posted $1.44 earnings per share. As a group, equities analysts predict that Tenet Healthcare will post 10.72 EPS for the current year.

Tenet Healthcare announced that its board has initiated a share repurchase program on Wednesday, July 24th that authorizes the company to buyback $1.50 billion in shares. This buyback authorization authorizes the company to purchase up to 10.3% of its shares through open market purchases. Shares buyback programs are often a sign that the company’s board believes its stock is undervalued.

Insider Buying and Selling

In other news, Director Meghan Fitzgerald sold 20,000 shares of the company’s stock in a transaction dated Tuesday, August 6th. The stock was sold at an average price of $146.34, for a total value of $2,926,800.00. Following the completion of the transaction, the director now directly owns 15,269 shares in the company, valued at approximately $2,234,465.46. This represents a 0.00 % decrease in their position. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through this link. In other news, Director Meghan Fitzgerald sold 20,000 shares of the business’s stock in a transaction that occurred on Tuesday, August 6th. The shares were sold at an average price of $146.34, for a total value of $2,926,800.00. Following the completion of the sale, the director now directly owns 15,269 shares in the company, valued at approximately $2,234,465.46. The trade was a 0.00 % decrease in their position. The sale was disclosed in a legal filing with the SEC, which can be accessed through this hyperlink. Also, CEO Saumya Sutaria sold 86,227 shares of the stock in a transaction on Wednesday, August 14th. The shares were sold at an average price of $154.41, for a total transaction of $13,314,311.07. Following the transaction, the chief executive officer now directly owns 13,773 shares in the company, valued at approximately $2,126,688.93. This represents a 0.00 % decrease in their position. The disclosure for this sale can be found here. Over the last ninety days, insiders sold 128,203 shares of company stock worth $19,754,997. Corporate insiders own 0.93% of the company’s stock.

Hedge Funds Weigh In On Tenet Healthcare

Institutional investors and hedge funds have recently bought and sold shares of the stock. Innealta Capital LLC purchased a new position in shares of Tenet Healthcare in the second quarter valued at about $28,000. ORG Wealth Partners LLC bought a new position in Tenet Healthcare during the 3rd quarter valued at approximately $30,000. ORG Partners LLC bought a new position in Tenet Healthcare during the 2nd quarter valued at approximately $31,000. Blue Trust Inc. raised its position in Tenet Healthcare by 93.0% during the 2nd quarter. Blue Trust Inc. now owns 249 shares of the company’s stock valued at $33,000 after purchasing an additional 120 shares during the last quarter. Finally, Kayne Anderson Rudnick Investment Management LLC bought a new position in Tenet Healthcare during the 2nd quarter valued at approximately $34,000. 95.44% of the stock is currently owned by institutional investors.

Tenet Healthcare Company Profile

(Get Free Report)

Tenet Healthcare Corporation operates as a diversified healthcare services company in the United States. The company operates through two segments: Hospital Operations and Services, and Ambulatory Care. Its general hospitals offer acute care services, operating and recovery rooms, radiology and respiratory therapy services, clinical laboratories, and pharmacies.

Recommended Stories

Analyst Recommendations for Tenet Healthcare (NYSE:THC)

Receive News & Ratings for Tenet Healthcare Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Tenet Healthcare and related companies with MarketBeat.com's FREE daily email newsletter.